• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Short Volatility Alert: IntriCon Corporation

    5/25/22 10:22:08 AM ET
    $IIN
    Medical/Dental Instruments
    Health Care
    Get the next $IIN alert in real time by email

    On Tuesday, shares of IntriCon Corporation (NASDAQ:IIN) experienced volatile short activity. After the activity, the stock price went up 0.4% to $24.24 The overall sentiment for IIN has been Bullish. The signal from the volatility alert is trending Bearish. Therefore, the recommendation is to Increase Short Exposure. The volatility alert was produced on the prior trading date, 5/24/2022, with a volatility change of +47.45%. The current volatility indicator stands at 8.519.

    Overview: The securities lending volatility indicator is produced by Tidal Markets, in partnership with Benzinga Insights. Securities lending primarily serves the purpose of providing liquidity to short sellers. When unusual activity occurs in the securities lending markets, it acts as an upstream indicator to what is likely to occur downstream in the regular stock market. Understanding the Volatility Alert: Overall sentiment is considered "bear" when broad market activity of the stock has been shown to indicate a negative directional basis, or is considered "bull" when indicating a positive directional basis. The securities lending volatility indicator provides a signal when it detects unusual short activity. Unusual short activity is based off a computer generated algorithmic formula utilizing securities lending trade details such as the volume of shares being shorted, the rate being paid to short the shares, and the type of collateral being posted - amongst other variables. The current volatility is the respective trading day's calculated securities lending volatility value. The volatility percentage change is the percentage difference in volatility between the two most recent days. The recommendation is a suggestive strategy, inferred from the strength of the Signal Trending, Current Volatility, and Volatility % Change. Recommendations may include, "Strong Buy", "Strong Sell", "Increase Short Exposure", "Reduce Short Exposure", or "Market Neutral". ANY INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE OR IMPLY INVESTMENT ADVICE

    Get the next $IIN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IIN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $IIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    B. Riley resumed coverage on IntriCon with a new price target

    B. Riley resumed coverage of IntriCon with a rating of Buy and set a new price target of $32.00 from $28.00 previously

    2/26/21 9:37:25 AM ET
    $IIN
    Medical/Dental Instruments
    Health Care

    $IIN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Intricon Announces Completion of Acquisition by an Affiliate of Altaris Capital Partners

    ARDEN HILLS, Minn., May 24, 2022 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ:IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced the completion of its acquisition by funds affiliated with Altaris Capital Partners, LLC (together with certain affiliated entities, "Altaris") for $24.25 per share in cash, or approximately $241 million on a fully diluted basis. The transaction was announced on February 28, 2022, and received approval from stockholders on May 24, 2022. As a result of the transaction, Intricon is now a privately he

    5/24/22 4:05:00 PM ET
    $IIN
    Medical/Dental Instruments
    Health Care

    Intricon Reports Fourth Quarter and Full Year 2021 Results

    ARDEN HILLS, Minn., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ:IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial results for its fourth quarter and year ended December 31, 2021. Fourth Quarter Highlights: Revenue of $32.2 million compared to $30.3 million in the prior year period Diabetes revenue increased 2% compared to the prior yearOther medical revenue increased 36.1% over the prior year period Gross profit margin of 25.2%, compared to 25.7% in the prior year periodNet income of $0.00 per di

    2/28/22 8:40:00 AM ET
    $IIN
    Medical/Dental Instruments
    Health Care

    Intricon Enters into Agreement to be Acquired by an Affiliate of Altaris Capital Partners for $241 Million

    ARDEN HILLS, Minn., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ:IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced that it has entered into a definitive agreement whereby an affiliate of Altaris Capital Partners, LLC (collectively with its affiliates, "Altaris"), an investment firm focused exclusively on the healthcare industry, will acquire the company. Under the terms of the agreement, Altaris will acquire all outstanding shares of Intricon for $24.25 per share in a transaction that values Intricon at an equ

    2/28/22 8:35:00 AM ET
    $IIN
    Medical/Dental Instruments
    Health Care

    $IIN
    SEC Filings

    View All

    SEC Form 15-12B filed by Intricon Corporation

    15-12B - INTRICON CORP (0000088790) (Filer)

    6/3/22 10:36:21 AM ET
    $IIN
    Medical/Dental Instruments
    Health Care

    Intricon Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - INTRICON CORP (0000088790) (Filer)

    5/25/22 3:55:57 PM ET
    $IIN
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 POS filed by Intricon Corporation

    S-8 POS - INTRICON CORP (0000088790) (Filer)

    5/24/22 5:07:27 PM ET
    $IIN
    Medical/Dental Instruments
    Health Care

    $IIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Giordano Nicholas A gifted 4,000 shares and returned 110,925 shares to the company, closing all direct ownership in the company

    4 - INTRICON CORP (0000088790) (Issuer)

    5/25/22 2:49:14 PM ET
    $IIN
    Medical/Dental Instruments
    Health Care

    SEC Form 4: Smith Philip Irving returned 16,327 shares to the company, closing all direct ownership in the company

    4 - INTRICON CORP (0000088790) (Issuer)

    5/25/22 2:43:53 PM ET
    $IIN
    Medical/Dental Instruments
    Health Care

    SEC Form 4: Gorder Mark Stephen returned 373,709 shares to the company, closing all direct ownership in the company

    4 - INTRICON CORP (0000088790) (Issuer)

    5/25/22 2:46:42 PM ET
    $IIN
    Medical/Dental Instruments
    Health Care

    $IIN
    Leadership Updates

    Live Leadership Updates

    View All

    Intricon Appoints Kathleen Pepski to its Board of Directors Intricon Corporation

    ARDEN HILLS, Minn., March 22, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering, and manufacturing miniature interventional, implantable and body-worn medical devices, today announced the appointment of Kathleen Pepski to the company’s Board of Directors, effective March 19, 2021. “We are delighted to welcome Kathleen to Intricon and our board of directors,” said Scott Longval, President and Chief Executive Officer of Intricon. “Kathleen is a well-respected business leader in Minneapolis whose background in manufacturing and distribution, as well as mergers and acquisitions, will be instrumental in our long

    3/22/21 8:00:00 AM ET
    $IIN
    Medical/Dental Instruments
    Health Care

    Intricon Corporation Announces Appointment of Chief Financial Officer

    ARDEN HILLS, Minn., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering, and manufacturing miniature interventional, implantable and body-worn medical devices, today announced that Ellen Scipta has been appointed Chief Financial Officer (CFO), effective immediately. As a key member of Intricon's executive leadership team, Ms. Scipta will lead the company’s financial operations and aid the management team on growing Intricon. “We are extremely pleased to welcome a strong leader like Ellen to the Intricon team. Her unique skill set that blends engineering with extensive financial experience will be inva

    2/8/21 4:05:00 PM ET
    $IIN
    Medical/Dental Instruments
    Health Care

    $IIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Intricon Corporation (Amendment)

    SC 13D/A - INTRICON CORP (0000088790) (Subject)

    5/26/22 4:04:17 PM ET
    $IIN
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D/A filed by Intricon Corporation (Amendment)

    SC 13D/A - INTRICON CORP (0000088790) (Subject)

    5/23/22 4:14:23 PM ET
    $IIN
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D/A filed by Intricon Corporation (Amendment)

    SC 13D/A - INTRICON CORP (0000088790) (Subject)

    5/19/22 4:06:37 PM ET
    $IIN
    Medical/Dental Instruments
    Health Care

    $IIN
    Financials

    Live finance-specific insights

    View All

    Intricon Reports Fourth Quarter and Full Year 2021 Results

    ARDEN HILLS, Minn., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ:IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial results for its fourth quarter and year ended December 31, 2021. Fourth Quarter Highlights: Revenue of $32.2 million compared to $30.3 million in the prior year period Diabetes revenue increased 2% compared to the prior yearOther medical revenue increased 36.1% over the prior year period Gross profit margin of 25.2%, compared to 25.7% in the prior year periodNet income of $0.00 per di

    2/28/22 8:40:00 AM ET
    $IIN
    Medical/Dental Instruments
    Health Care

    Intricon Reports Third Quarter 2021 Results

    ARDEN HILLS, Minn., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ:IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial results for its third quarter ended September 30, 2021. Third Quarter 2021 Highlights: Revenue of $31.1 million, a 13.5% increase compared to the prior year periodGross profit margin of 23.1%, compared to 26.3% in the prior year periodGAAP net income of $337,000 versus net income of $644,000 in the prior year periodNon-GAAP adjusted net income of $1.7 million versus $2.4 m

    11/8/21 4:05:00 PM ET
    $IIN
    Medical/Dental Instruments
    Health Care

    Intricon Announces CFO Departure and Preliminary Third Quarter 2021 Revenue

    ARDEN HILLS, Minn., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ:IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, announced today that Ellen Scipta has stepped down from her position as Chief Financial Officer, effective October 29, 2021. Annalee Lutgen, current Treasurer and Director of Finance, will serve as interim Chief Financial Officer effective upon Ms. Scipta's resignation as the company conducts its search for a permanent replacement. "We appreciate the contributions Ellen has made to Intricon during her tenure h

    10/29/21 4:05:00 PM ET
    $IIN
    Medical/Dental Instruments
    Health Care